Price to Book Value Chart

View Price to Book Value for GUTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2024. Start Trial.
Date Value
June 29, 2026 5.905
June 26, 2026 5.514
June 25, 2026 5.929
June 24, 2026 5.752
June 23, 2026 6.138
June 22, 2026 6.449
June 18, 2026 6.37
June 17, 2026 6.308
June 16, 2026 5.759
June 15, 2026 6.308
June 12, 2026 6.308
June 11, 2026 5.373
June 10, 2026 5.431
June 09, 2026 4.929
June 08, 2026 4.972
June 05, 2026 5.036
June 04, 2026 5.445
June 03, 2026 5.640
June 02, 2026 5.861
June 01, 2026 6.436
May 29, 2026 5.983
May 28, 2026 6.242
May 27, 2026 6.377
May 26, 2026 6.812
May 22, 2026 6.751
Date Value
May 21, 2026 6.828
May 20, 2026 6.838
May 19, 2026 6.064
May 18, 2026 5.985
May 15, 2026 6.387
May 14, 2026 7.080
May 13, 2026 7.038
May 12, 2026 5.448
May 11, 2026 5.707
May 08, 2026 5.601
May 07, 2026 5.552
May 06, 2026 5.456
May 05, 2026 5.150
May 04, 2026 5.396
May 01, 2026 5.19
April 30, 2026 4.731
April 29, 2026 4.468
April 28, 2026 4.871
April 27, 2026 4.847
April 24, 2026 4.601
April 23, 2026 4.312
April 22, 2026 4.382
April 21, 2026 4.268
April 20, 2026 4.271
April 17, 2026 4.226

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Co-Diagnostics, Inc. 0.4836
Spectral AI, Inc. --
Vaxcyte, Inc. 3.210
Moderna, Inc. 8.426
Arrowhead Pharmaceuticals, Inc. 26.86

Price to Book Value Related Metrics

Price 0.7418
Earnings Yield -147.4%
Market Cap 117.69M